MWM
ACHN

MinichMacGregor Wealth Management’s Achillion Pharmaceuticals ACHN Stock Holding History

MinichMacGregor Wealth Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,740
Closed -$7K – 546
2017
Q3 		$7K Hold
1,740
– – 0.01% 327
2017
Q2 		$7K Hold
1,740
– – 0.01% 326
2017
Q1 		$7K Hold
1,740
– – 0.01% 326
2016
Q4 		$7K Hold
1,740
– – 0.01% 320
2016
Q3 		$14K Hold
1,740
– – 0.01% 227
2016
Q2 		$13K Hold
1,740
– – 0.01% 226
2016
Q1 		$13K Buy
1,740
+850
+96% +$6.22K 0.01% 215
2015
Q4 		$8K Buy
+890
New +$8.09K 0.01% 262

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MinichMacGregor Wealth Management's ACHN Position: Q4 2017 in Review

MinichMacGregor Wealth Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2017, closing a stake of 1,740 shares — an estimated $7K sold.

MinichMacGregor Wealth Management first reported a position in ACHN in Q4 2015 and held it in 8 quarters. The position peaked at $14K in Q3 2016. 149 funds tracked by Wall St. Rank hold ACHN as of Q4 2017.

  • MinichMacGregor Wealth Management reported no remaining Achillion Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 1,740 Achillion Pharmaceuticals shares in Q4 2017, an estimated $7K.
  • MinichMacGregor Wealth Management first reported a position in Achillion Pharmaceuticals in Q4 2015 and held it in 8 quarters.
  • MinichMacGregor Wealth Management's Achillion Pharmaceuticals position peaked at $14K in Q3 2016.
  • 149 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2017.

Based on MinichMacGregor Wealth Management's 13F filing for Q4 2017, filed 3 Jul 2018.